Fig. 5From: Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysisForest plot of safety. a Forest plot of grade 3–4 adverse events. b Forest plot of all-cause mortality. c Forest plot of completed treatmentBack to article page